Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems

PLoS Pathogens

Volumn 8, Issue 5, 2012, Pages

  Scheel, Troels K H ^a   Prentoe, Jannick ^a   Carlsen, Thomas H R ^a   Mikkelsen, Lotte S ^a   Gottwein, Judith M ^a   Bukh, Jens ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 5A; PROLINE; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; P7 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN; VIRUS RNA;

ALPHA HELIX; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE DELETION; GENETIC LINKAGE; GENOTYPE; HEPATITIS C VIRUS; NONHUMAN; PROTEIN MODIFICATION; REPLICON; REVERSE GENETICS; SEQUENCE ANALYSIS; VIRUS ISOLATION; VIRUS MUTATION; VIRUS RECOMBINANT; VIRUS REPLICATION; CHEMISTRY; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN SECONDARY STRUCTURE; TUMOR CELL LINE; VIRUS ASSEMBLY;

HEPATITIS C VIRUS;

BASE SEQUENCE; CELL LINE, TUMOR; GENOTYPE; HEPACIVIRUS; HUMANS; PROTEIN STRUCTURE, SECONDARY; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 84863682657     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002696     Document Type: Article

References (63)

1. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, et al. (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42: 962-973.
2. Murphy DG, Chamberland J, Dandavino R, Sablon E, (2007) A new genotype of hepatitis C virus originating from central Africa. Hepatology 46: 623A.
3. Prentoe JC, Jensen TB, Meuleman P, Serre SB, Scheel TK, et al. (2011) Hypervariable region 1 differentially impacts viability of hepatitis C genotype 1-6 strains and impairs virus neutralization. J Virol 85: 2224-2234.
4. Meunier JC, Engle RE, Faulk K, Zhao M, Bartosch B, et al. (2005) Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci U S A 102: 4560-4565.
5. Scheel TK, Gottwein JM, Jensen TB, Prentoe JC, Hoegh AM, et al. (2008) Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proc Natl Acad Sci U S A 105: 997-1002.
6. Jensen TB, Gottwein JM, Scheel TK, Hoegh AM, Eugen-Olsen J, et al. (2008) Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection. J Infect Dis 198: 1756-1765.
7. Gottwein JM, Scheel TK, Jensen TB, Lademann JB, Prentoe JC, et al. (2009) Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49: 364-377.
8. Manns MP, Wedemeyer H, Cornberg M, (2006) Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55: 1350-1359.
9. Gottwein JM, Bukh J, (2008) Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems. Adv Virus Res 71: 51-133.
10. Shimakami T, Lanford RE, Lemon SM, (2009) Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalities. Curr Opin Pharmacol 9: 537-544.
11. Fridell RA, Qiu D, Wang C, Valera L, Gao M, (2010) Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System. Antimicrob Agents Chemother 54: 3641-3650.
12. Scheel TK, Gottwein JM, Mikkelsen LS, Jensen TB, Bukh J, (2011) Recombinant HCV Variants with NS5A from Genotypes 1-7 Have Different Sensitivities to an NS5A Inhibitor but Not Interferon-alpha. Gastroenterology 140: 1032-1042.
13. Sarrazin C, Zeuzem S, (2010) Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection. Gastroenterology 138: 447-462.
14. Gao M, Nettles RE, Belema M, Snyder LB, Nguyen VN, et al. (2010) Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 765: 96-100.
15. Gosert R, Egger D, Lohmann V, Bartenschlager R, Blum HE, et al. (2003) Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J Virol 77: 5487-5492.
16. Tellinghuisen TL, Marcotrigiano J, Gorbalenya AE, Rice CM, (2004) The NS5A protein of hepatitis C virus is a zinc metalloprotein. J Biol Chem 279: 48576-48587.
17. Brass V, Bieck E, Montserret R, Wolk B, Hellings JA, et al. (2002) An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J Biol Chem 277: 8130-8139.
18. Penin F, Brass V, Appel N, Ramboarina S, Montserret R, et al. (2004) Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A. J Biol Chem 279: 40835-40843.
19. Tellinghuisen TL, Marcotrigiano J, Rice CM, (2005) Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435: 374-379.
20. Love RA, Brodsky O, Hickey MJ, Wells PA, Cronin CN, (2009) Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus. J Virol 83: 4395-4403.
21. Huang L, Hwang J, Sharma SD, Hargittai MR, Chen Y, et al. (2005) Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein. J Biol Chem 280: 36417-36428.
22. Elazar M, Cheong KH, Liu P, Greenberg HB, Rice CM, et al. (2003) Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol 77: 6055-6061.
23. Tellinghuisen TL, Foss KL, Treadaway JC, Rice CM, (2008) Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein. J Virol 82: 1073-1083.
24. Gale M Jr, Blakely CM, Kwieciszewski B, Tan SL, Dossett M, et al. (1998) Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18: 5208-5218.
25. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, et al. (1996) Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334: 77-81.
26. Hofmann WP, Zeuzem S, Sarrazin C, (2005) Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy. J Clin Virol 32: 86-91.
27. Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, et al. (2008) Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 4: e1000035.
28. Tellinghuisen TL, Foss KL, Treadaway J, (2008) Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog 4: e1000032.
29. Masaki T, Suzuki R, Murakami K, Aizaki H, Ishii K, et al. (2008) Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol 82: 7964-7976.
30. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.
31. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 623-626.
32. Bukh J, Pietschmann T, Lohmann V, Krieger N, Faulk K, et al. (2002) Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci U S A 99: 14416-14421.
33. Blight KJ, Kolykhalov AA, Rice CM, (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290: 1972-1974.
34. Lohmann V, Hoffmann S, Herian U, Penin F, Bartenschlager R, (2003) Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J Virol 77: 3007-3019.
35. Kolykhalov AA, Mihalik K, Feinstone SM, Rice CM, (2000) Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo. J Virol 74: 2046-2051.
36. Brass V, Berke JM, Montserret R, Blum HE, Penin F, et al. (2008) Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex. Proc Natl Acad Sci U S A 105: 14545-14550.
37. Lindstrom H, Lundin M, Haggstrom S, Persson MA, (2006) Mutations of the Hepatitis C virus protein NS4B on either side of the ER membrane affect the efficiency of subgenomic replicons. Virus Res 121: 169-178.
38. Krieger N, Lohmann V, Bartenschlager R, (2001) Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75: 4614-4624.
39. Gottwein JM, Jensen TB, Mathiesen CK, Meuleman P, Serre SB, et al. (2011) Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A. J Virol 85: 8913-8928.
40. Russell RS, Meunier JC, Takikawa S, Faulk K, Engle RE, et al. (2008) Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc Natl Acad Sci U S A 105: 4370-4375.
41. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, et al. (2006) Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A 103: 7408-7413.
42. Hughes M, Gretton S, Shelton H, Brown DD, McCormick CJ, et al. (2009) A conserved proline between domains II and III of hepatitis C virus NS5A influences both RNA replication and virus assembly. J Virol 83: 10788-10796.
43. Tan SL, Nakao H, He Y, Vijaysri S, Neddermann P, et al. (1999) NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 96: 5533-5538.
44. Macdonald A, Crowder K, Street A, McCormick C, Harris M, (2004) The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J Gen Virol 85: 721-729.
45. Appel N, Pietschmann T, Bartenschlager R, (2005) Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain. J Virol 79: 3187-3194.
46. Pietschmann T, Zayas M, Meuleman P, Long G, Appel N, et al. (2009) Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations. PLoS Pathog 5: e1000475.
47. Schmitz U, Tan SL, (2008) NS5A-from obscurity to new target for HCV therapy. Recent Pat Antiinfect Drug Discov 3: 77-92.
48. You S, Rice CM, (2008) 3′ RNA elements in hepatitis C virus replication: kissing partners and long poly(U). J Virol 82: 184-195.
49. Hughes M, Griffin S, Harris M, (2009) Domain III of NS5A contributes to both RNA replication and assembly of hepatitis C virus particles. J Gen Virol 90: 1329-1334.
50. Kim S, Welsch C, Yi M, Lemon SM, (2011) Regulation of the production of infectious genotype 1a hepatitis C virus by NS5A domain III. J Virol 85: 6645-6656.
51. Backes P, Quinkert D, Reiss S, Binder M, Zayas M, et al. (2010) Role of annexin A2 in the production of infectious hepatitis C virus particles. J Virol 84: 5775-5789.
52. Ide Y, Zhang L, Chen M, Inchauspe G, Bahl C, et al. (1996) Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Gene 182: 203-211.
53. Gottwein JM, Scheel TK, Jensen TB, Ghanem L, Bukh J, (2011) Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3/4A protease recombinant viruses. Gastroenterology 141: 1067-1079.
54. Ma Y, Yates J, Liang Y, Lemon SM, Yi M, (2008) NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J Virol 82: 7624-7639.
55. Jirasko V, Montserret R, Lee JY, Gouttenoire J, Moradpour D, et al. (2010) Structural and functional studies of nonstructural protein 2 of the hepatitis C virus reveal its key role as organizer of virion assembly. PLoS Pathog 6: e1001233.
56. Ma Y, Anantpadma M, Timpe JM, Shanmugam S, Singh SM, et al. (2011) Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by interacting with both structural and nonstructural proteins. J Virol 85: 86-97.
57. Tedbury P, Welbourn S, Pause A, King B, Griffin S, et al. (2011) The subcellular localization of the hepatitis C virus non-structural protein NS2 is regulated by an ion channel-independent function of the p7 protein. J Gen Virol 92: 819-830.
58. Stapleford KA, Lindenbach BD, (2011) Hepatitis C Virus NS2 Coordinates Virus Particle Assembly through Physical Interactions with the E1-E2 Glycoprotein and NS3-NS4A Enzyme Complexes. J Virol 85: 1706-1717.
59. Murray CL, Jones CT, Tassello J, Rice CM, (2007) Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Infectious Virus Production. J Virol 81: 10220-10231.
60. Gottwein JM, Scheel TK, Hoegh AM, Lademann JB, Eugen-Olsen J, et al. (2007) Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 133: 1614-1626.
61. Scheel TK, Gottwein JM, Carlsen TH, Li YP, Jensen TB, et al. (2011) Efficient culture adaptation of hepatitis C virus intergenotypic JFH1-based Core-NS2 recombinants by using previously identified mutations. J Virol 85: 2891-2906.
62. Crooks GE, Hon G, Chandonia JM, Brenner SE, (2004) WebLogo: a sequence logo generator. Genome Res 14: 1188-1190.
63. Schneider TD, Stephens RM, (1990) Sequence logos: a new way to display consensus sequences. Nucleic Acids Res 18: 6097-6100.